Dr. Beth Baker, MD

NPI: 1184606956
Total Payments
$796.55
2019 Payments
$73.82
Companies
5
Transactions
17
Medicare Patients
1,692
Medicare Billing
$91,733

Payment Breakdown by Category

Food & Beverage$758.55 (95.2%)
Education$38.00 (4.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $758.55 16 95.2%
Education $38.00 1 4.8%

Top Paying Companies

Company Total Records Latest Year
GlaxoSmithKline, LLC. $514.78 5 $0 (2019)
Genentech USA, Inc. $155.78 3 $0 (2019)
Sunovion Pharmaceuticals Inc. $57.79 7 $0 (2017)
Mylan Specialty L.P. $49.00 1 $0 (2018)
Boehringer Ingelheim Pharmaceuticals, Inc. $19.20 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2019 $73.82 3 Genentech USA, Inc. ($55.67)
2018 $168.31 3 Genentech USA, Inc. ($100.11)
2017 $554.42 11 GlaxoSmithKline, LLC. ($496.63)

All Payment Transactions

17 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/18/2019 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $18.15 General
Category: RESPIRATORY
11/19/2019 Genentech USA, Inc. Esbriet (Biological) Food and Beverage In-kind items and services $17.67 General
Category: Immunology
02/25/2019 Genentech USA, Inc. Esbriet (Biological) Education In-kind items and services $38.00 General
Category: Immunology
10/15/2018 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $19.20 General
10/09/2018 Mylan Specialty L.P. Food and Beverage In-kind items and services $49.00 General
08/21/2018 Genentech USA, Inc. Esbriet (Biological) Food and Beverage In-kind items and services $100.11 General
Category: Immunology
12/06/2017 GlaxoSmithKline, LLC. INCRUSE (Drug) Food and Beverage In-kind items and services $98.13 General
Category: RESPIRATORY
08/18/2017 Sunovion Pharmaceuticals Inc. UTIBRON (Drug) Food and Beverage In-kind items and services $14.43 General
Category: RESPIRATORY
08/18/2017 Sunovion Pharmaceuticals Inc. BROVANA (Drug) Food and Beverage In-kind items and services $7.13 General
Category: RESPIRATORY
07/14/2017 Sunovion Pharmaceuticals Inc. BROVANA (Drug) Food and Beverage In-kind items and services $5.62 General
Category: RESPIRATORY
06/16/2017 Sunovion Pharmaceuticals Inc. BROVANA (Drug) Food and Beverage In-kind items and services $9.21 General
Category: RESPIRATORY
06/16/2017 Sunovion Pharmaceuticals Inc. BROVANA (Drug) Food and Beverage In-kind items and services $7.95 General
Category: RESPIRATORY
05/11/2017 GlaxoSmithKline, LLC. ANORO ELLIPTA (Drug) Food and Beverage In-kind items and services $125.00 General
Category: RESPIRATORY
05/10/2017 GlaxoSmithKline, LLC. ANORO (Drug) Food and Beverage In-kind items and services $3.38 General
Category: RESPIRATORY
05/09/2017 Sunovion Pharmaceuticals Inc. UTIBRON (Drug) Food and Beverage In-kind items and services $6.95 General
Category: RESPIRATORY
03/01/2017 Sunovion Pharmaceuticals Inc. BROVANA (Drug) Food and Beverage In-kind items and services $6.50 General
Category: RESPIRATORY
01/11/2017 GlaxoSmithKline, LLC. Food and Beverage In-kind items and services $270.12 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 297 297 $43,710 $6,127
2022 8 310 311 $84,984 $13,227
2021 8 359 372 $172,305 $26,630
2020 15 726 758 $275,672 $45,748
Total Patients
1,692
Total Services
1,738
Medicare Billing
$91,733
Procedure Codes
39

All Medicare Procedures & Services

39 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
95811 Sleep study in sleep lab with continuous airway pressure (6 years or older) Office 2023 15 15 $16,500 $1,973 12.0%
99202 New patient office or other outpatient visit, 15-29 minutes Office 2023 17 17 $3,910 $1,090 27.9%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 21 21 $3,171 $940.19 29.6%
94726 Test to determine lung volumes using sensors Facility 2023 79 79 $4,740 $823.04 17.4%
94729 Test to examine how well the lungs exchange gases Facility 2023 81 81 $7,533 $628.63 8.3%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Facility 2023 41 41 $4,674 $351.36 7.5%
94010 Test to measure expiratory airflow and volume Facility 2023 43 43 $3,182 $321.16 10.1%
95811 Sleep study in sleep lab with continuous airway pressure (6 years or older) Office 2022 37 37 $40,700 $4,776 11.7%
99202 New patient office or other outpatient visit, 15-29 minutes Office 2022 66 66 $15,180 $3,879 25.6%
95810 Sleep study in sleep lab (6 years or older) Office 2022 12 12 $12,000 $1,469 12.2%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 27 28 $4,228 $1,357 32.1%
94726 Test to determine lung volumes using sensors Facility 2022 53 53 $3,021 $673.73 22.3%
94729 Test to examine how well the lungs exchange gases Facility 2022 56 56 $4,984 $527.07 10.6%
94010 Test to measure expiratory airflow and volume Facility 2022 40 40 $2,800 $327.72 11.7%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Facility 2022 19 19 $2,071 $218.84 10.6%
95811 Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube Office 2021 79 82 $90,200 $11,308 12.5%
99202 New patient outpatient visit, total time 15-29 minutes Office 2021 99 99 $22,770 $6,300 27.7%
95810 Sleep monitoring of patient (6 years or older) in sleep lab Office 2021 41 41 $41,000 $5,259 12.8%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 50 60 $9,060 $2,799 30.9%
94726 Determination of lung volumes using plethysmography Facility 2021 28 28 $1,617 $365.30 22.6%
94729 Measurement of lung diffusing capacity Facility 2021 30 30 $1,589 $290.05 18.3%
94010 Measurement and graphic recording of total and timed exhaled air capacity Facility 2021 20 20 $2,791 $186.00 6.7%
94060 Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration Facility 2021 12 12 $3,278 $123.93 3.8%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 120 136 $69,360 $12,550 18.1%
99205 New patient office or other outpatient visit, typically 60 minutes Office 2020 39 39 $38,142 $6,242 16.4%

About Dr. Beth Baker, MD

Dr. Beth Baker, MD is a Pulmonary Disease healthcare provider based in Anchorage, Alaska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1184606956.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Beth Baker, MD has received a total of $796.55 in payments from pharmaceutical and medical device companies, with $73.82 received in 2019. These payments were reported across 17 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($758.55).

As a Medicare-enrolled provider, Baker has provided services to 1,692 Medicare beneficiaries, totaling 1,738 services with total Medicare billing of $91,733. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.

Practice Information

  • Specialty Pulmonary Disease
  • Location Anchorage, AK
  • Active Since 11/17/2005
  • Last Updated 08/03/2018
  • Taxonomy Code 207RP1001X
  • Entity Type Individual
  • NPI Number 1184606956

Products in Payments

  • Esbriet (Biological) $155.78
  • ANORO ELLIPTA (Drug) $125.00
  • INCRUSE (Drug) $98.13
  • BROVANA (Drug) $36.41
  • UTIBRON (Drug) $21.38
  • NUCALA (Biological) $18.15
  • ANORO (Drug) $3.38

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pulmonary Disease Doctors in Anchorage